💊 Immunosuppressant • Transplant Medicine • Sirolimus

Rapacan 1 mg — Complete Guide to Sirolimus (Generic Rapamune)

📋 Biocon Limited • Kidney Transplant Prophylaxis • Immunosuppression • 6 min read

🧫 Watch: Understanding how Sirolimus (Rapacan) helps prevent organ rejection and supports long-term transplant survival.

🧾 Product Overview

🧬 Active Ingredient	Sirolimus
💊 Indication	Organ transplant rejection prophylaxis, LAM (off-label)
🇺🇸 US Brand Equivalent	Rapamune
🏭 Manufacturer	Biocon Limited, India
📦 Packaging	10 tablets per strip
💊 Strength	1 mg
🚚 Delivery Time	6 to 15 days (Ships globally: USA, UK, Australia)

🧬 What is Rapacan (Sirolimus)?

Rapacan is a generic version of Sirolimus, an immunosuppressant drug manufactured by Biocon Limited. It is primarily used to prevent rejection in patients who have received kidney transplants. Sirolimus works by inhibiting T-cell activation and proliferation, which helps the body accept a transplanted organ.

Sirolimus is also used off-label for treating lymphangioleiomyomatosis (LAM), a rare lung disease, and has shown potential in certain autoimmune and dermatological conditions. Rapacan is recognized for its affordability and bioequivalence to Rapamune, the US brand.

💡 Key Mechanism: Sirolimus binds to FKBP-12, forming a complex that inhibits mTOR (mammalian target of rapamycin), blocking T-cell proliferation and preventing graft rejection.

🩺 Expert Commentary

🗓️ Reviewed: June 27, 2026

“Rapacan provides stable immunosuppression with a lower risk of nephrotoxicity compared to calcineurin inhibitors like tacrolimus and cyclosporine. It’s ideal for long-term kidney transplant care, particularly in patients with renal dysfunction or those at risk of viral infections. However, monitoring drug levels and lipid profiles is essential.”

— Dr. Rehan Thomas, Transplant Nephrologist

💉 Dosage & Administration

💡 Indication	💊 Recommended Dose	⏱️ Notes
Kidney Transplant Prophylaxis	2–5 mg/day initially	Adjust based on trough levels
Maintenance Therapy	1–4 mg/day	Monitor blood sirolimus levels
LAM (off-label)	1–2 mg/day	Specialist-supervised dosing

📌 Important: Take orally once daily, consistently with or without food. Regular monitoring of sirolimus blood trough levels is essential for dose adjustment and safety.

⚠️ Side Effects, Storage & Precautions

Common Side Effects

Hyperlipidemia
Anemia
Mouth ulcers
Delayed wound healing
Peripheral edema

Serious Side Effects

Thrombocytopenia
Interstitial lung disease
Hepatic dysfunction
Thrombotic microangiopathy
Hypersensitivity reactions

⚠️ Precautions: Avoid live vaccines and contact with people who have infections. Regular monitoring of lipid panel, CBC, liver/kidney function, and drug levels is required.

Storage: Store below 25°C (77°F) in a dry, protected place away from moisture and direct sunlight.
Shelf Life: Check expiration date on packaging before use.
Pregnancy: Contraindicated during pregnancy due to fetal toxicity risk.

🌍 Global Shipping & Availability

🌎 Country	📦 Shipping Available	💵 Price Estimate (10 tablets)	📜 Prescription Required
🇺🇸 USA	✅ Yes	$22–$30	Yes
🇬🇧 UK	✅ Yes	£18–£25	Yes
🇦🇺 Australia	✅ Yes	AUD 35–45	Yes

📦 Delivery via certified Indian exporters with tracking. Discreet and temperature-controlled shipping for sensitive medications.

🔗 Related Indian Alternatives (Internal Links)

💊 Product Name	🏭 Manufacturer	🔗 Link
Siromus 1mg	Zydus Cadila	Siromus 1mg
Siroboon 1mg	Neon Labs	View Product →
Siropan 1mg	Panacea Biotec	Siropan 1mg
Rapacan 2mg	Biocon Limited	View Product →
Tacloran 1mg	Biocon Limited	Tacloran 1mg

📖 Understanding Sirolimus Therapy in Transplantation

Sirolimus (Rapacan) is a cornerstone immunosuppressant in modern transplant medicine. Its unique mechanism of action offers several advantages over traditional calcineurin inhibitors:

🩺

Lower Nephrotoxicity

Unlike calcineurin inhibitors, sirolimus does not directly damage kidney tissue, making it valuable for patients with renal impairment.

🛡️

Anti-Cancer Properties

Sirolimus has shown anti-proliferative effects that may reduce the risk of certain post-transplant malignancies.

🧬

Long-Term Graft Survival

Studies suggest sirolimus-based regimens may improve long-term graft survival compared to traditional regimens.

According to transplant guidelines, sirolimus is particularly beneficial in:

Patients with delayed graft function
Individuals at high risk of viral infections (CMV, EBV)
Patients with pre-existing renal dysfunction
Those requiring steroid-sparing regimens

❓ Frequently Asked Questions

What is Rapacan used for?

Rapacan (Sirolimus) is primarily used to prevent organ rejection in kidney transplant patients. It is also used off-label for treating lymphangioleiomyomatosis (LAM) and certain autoimmune conditions.

How is Rapacan different from calcineurin inhibitors?

Rapacan (Sirolimus) works by inhibiting mTOR, not calcineurin. It has lower kidney toxicity but requires monitoring of blood lipids and drug levels. It is often used alongside reduced-dose calcineurin inhibitors.

What monitoring is required during Rapacan therapy?

Regular monitoring of sirolimus blood trough levels, lipid panel, complete blood count, and liver/kidney function is essential. Therapeutic drug monitoring ensures efficacy and safety.

Can Rapacan be used with other immunosuppressants?

Yes — Rapacan is often used in combination with calcineurin inhibitors (tacrolimus, cyclosporine) and corticosteroids. The combination regimen should be individualized based on transplant type and patient factors.

Is Rapacan safe during pregnancy?

Sirolimus is contraindicated during pregnancy due to fetal toxicity risk. Effective contraception should be used during treatment and for 12 weeks after stopping.

📚 External Resources

🩺 Medical Disclaimer

This content is for informational and educational purposes only and does not constitute medical advice. Rapacan (Sirolimus) is a prescription immunosuppressant that should only be used under the supervision of a qualified healthcare professional, typically a transplant specialist. Always consult your healthcare provider before beginning, changing, or discontinuing any medication. Never self-prescribe or share prescription medications with others. Immunosuppressive therapy carries significant risks and requires regular medical monitoring.